U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H18N2O3
Molecular Weight 226.2722
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AMOBARBITAL

SMILES

CCC1(CCC(C)C)C(=O)NC(=O)NC1=O

InChI

InChIKey=VIROVYVQCGLCII-UHFFFAOYSA-N
InChI=1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)

HIDE SMILES / InChI

Molecular Formula C11H18N2O3
Molecular Weight 226.2722
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

AMOBARBITAL is a barbiturate derivative with hypnotic and sedative properties. In an in vitro study in rat thalamic slices amobarbital worked by activating GABAA receptors, which decreased input resistance, depressed burst and tonic firing, especially in ventrobasal and intralaminar neurons, while at the same time increasing burst duration and mean conductance at individual chloride channels; this increased both the amplitude and decay time of inhibitory postsynaptic currents. Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Amytal Sodium

Approved Use

Unknown
Primary
Amytal Sodium

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Seven cases of somnambulism induced by drugs.
1979 Jul
The central nervous effects of Mitragyna africanus (Willd) stembark extract in rats.
2001 Oct
Mitochondrial respiratory chain as a new target for anti-ischemic molecules.
2002 Apr 19
Transcortical mixed aphasia due to cerebral infarction in left inferior frontal lobe and temporo-parietal lobe.
2002 Feb
Effect of the new matrix metalloproteinase inhibitor RO-28-2653 on mitochondrial function.
2002 Feb 15
Wada testing reveals frontal lateralization for the memorization of words and faces.
2002 Jan 1
Amobarbital inhibits K(+)-stimulated glucose oxidation in cerebellar granule neurons by two mechanisms.
2002 Jun 20
Key structural features of ligands for activation of human pregnane X receptor.
2004 Apr
Neurophysiologic monitoring and pharmacologic provocative testing for embolization of spinal cord arteriovenous malformations.
2004 Aug
Endovascular management of dolichoectasia of the posterior cerebral artery report.
2004 Nov-Dec
Selective GABA-receptor actions of amobarbital on thalamic neurons.
2004 Oct
Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy in high myopia: a prospective clinical study.
2004 Sep 14
[Rotenone-insensitive NADH oxydation in mitochondrial suspension occurs by NADH dehydrogenase of respiratory chain fragments].
2004 Sep-Oct
Role of endothelial mitochondria in oxidant production and modulation of neutrophil adherence.
2004 Sep-Oct
Amytal interview using intravenous lorazepam in a patient with dissociative fugue.
2006 Nov-Dec
Different states of energy metabolism in the vertebrate retina can be identified by stimulus-related changes in near UV transmission.
2007 Apr
Comorbid substance-use in schizophrenia: the file drawer effect, In reply to: Talamo et al., 2006. "Comorbid substance-use in schizophrenia: relation to positive and negative symptoms".
2007 Feb
Seizures during intracarotid methohexital and amobarbital testing.
2007 Feb
In silico prediction of pregnane X receptor activators by machine learning approaches.
2007 Jan
[Applications of optical topography in neurosurgery].
2007 May
Perioperative modulating factors on astigmatism in sutured cataract surgery.
2009 Dec
Acquired and congenital disorders of sung performance: A review.
2009 Nov 12
Multiple myeloma presenting as CEA-producing rectal cancer.
2010 Mar 31
Identification of a novel phosphorylation site in hepatitis C virus NS5A.
2010 Oct
Patents

Patents

Sample Use Guides

Sedative: 30 to 50 mg given 2 or 3 times daily. Hypnotic: 65 to 200 mg at bedtime.
Route of Administration: Oral
In Vitro Use Guide
To 100mkl of the tissue homogenate were added 50 mkl of [3SS]TBPS (at the appropriate concentration, and made in 1 M NaBr), 50 mkl of 50 mM Tris Citrate buffer (to define total binding) or AMOBARBITAL at 100mkM or 50mkl of 40mkM picrotoxinin (to define nonspecific binding). The mixture was incubated 90 min at 21°C and then filtered over glass-fiber filters (Schleicher and Schuell No. 32). Filters were washed three times with 5 ml 0.9% (w:v) NaC1 equilibrated to 21°C and then counted by liquid scintillation spectrometry.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:01:04 GMT 2023
Edited
by admin
on Fri Dec 15 15:01:04 GMT 2023
Record UNII
GWH6IJ239E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AMOBARBITAL
EP   HSDB   INN   MART.   MI   VANDF   WHO-DD  
INN  
Official Name English
amobarbital [INN]
Common Name English
ISOMYTAL
Brand Name English
AMOBARBITAL [VANDF]
Common Name English
AMOBARBITAL [MART.]
Common Name English
AMOBARBITAL [JAN]
Common Name English
AMOBARBITAL CII [USP-RS]
Common Name English
5-Ethyl-5-isopentylbarbituric acid
Systematic Name English
Amobarbital [WHO-DD]
Common Name English
2,4,6(1H,3H,5H)-PYRIMIDINETRIONE, 5-ETHYL-5-(3-METHYLBUTYL)-
Systematic Name English
AMOBARBITAL [EP IMPURITY]
Common Name English
NSC-10815
Code English
AMOBARBITAL CII
USP-RS  
Common Name English
AMYTAL
Brand Name English
AMOBARBITAL [HSDB]
Common Name English
AMOBARBITAL [MI]
Common Name English
Classification Tree Code System Code
WHO-VATC QN05CA02
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
NCI_THESAURUS C67084
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
WHO-ATC N05CA02
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
DEA NO. 2125
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
LIVERTOX 46
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
Code System Code Type Description
FDA UNII
GWH6IJ239E
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
RXCUI
719
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY RxNorm
MESH
D000654
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
DRUG BANK
DB01351
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
ECHA (EC/EINECS)
200-330-7
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
DRUG CENTRAL
184
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
DAILYMED
GWH6IJ239E
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
INN
1111
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
CAS
57-43-2
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
SMS_ID
100000087425
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
PUBCHEM
2164
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
CHEBI
2673
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
EPA CompTox
DTXSID9020081
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
HSDB
3286
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
EVMPD
SUB05468MIG
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
RS_ITEM_NUM
1030001
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
WIKIPEDIA
AMOBARBITAL
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
ChEMBL
CHEMBL267894
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
NSC
10815
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
MERCK INDEX
m1837
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C76523
Created by admin on Fri Dec 15 15:01:04 GMT 2023 , Edited by admin on Fri Dec 15 15:01:04 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC